Developing a Fully Individualized mRNA Cancer Immunotherapy: Regulatory Innovation & Challenges
Time: 9:00 am
day: Conference Day Two
Details:
- Lessons learned from the development of fully individualized mRNA immunotherapy across multiple tumor types
- Key questions to identify the most appropriate development strategy
- Navigating an evolving regulatory landscape and identifying the areas of uncertainty
